Life Sciences › Securities & Exchange Commission

Skadden's 2013 Insights

We are pleased to provide a collection of commentaries on the critical legal issues facing our clients in 2013. There is hope that global economic and market conditions will continue to improve despite ongoing...more

Life Sciences - Spin-off Transactions

Spin-off transactions can be beneficial, but they are complicated, time-consuming and expensive, and can trigger lawsuits and other problems for the parent company if not carefully planned and implemented. This Client Alert...more